{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:47:21Z","timestamp":1788583641062,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.coph.2024.102433","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T09:26:38Z","timestamp":1706174798000},"page":"102433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Analgesic potential of voltage gated sodium channel modulators for the management of pain"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-3428","authenticated-orcid":false,"given":"Jason J.","family":"McDougall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2024.102433_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-020-00415-2","article-title":"Status of peripheral sodium channel blockers for non-addictive pain treatment","volume":"16","author":"Alsaloum","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.coph.2024.102433_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48118","article-title":"Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation","volume":"8","author":"Lee","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.coph.2024.102433_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-3565(25)28443-9","article-title":"The site of action and active form of local anesthetics. II. Experiments with quaternary compounds","volume":"171","author":"Frazier","year":"1970","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2024.102433_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/ALN.0000000000001050","article-title":"Quaternary lidocaine derivative QX-314 activates and permeates human TRPV1 and TRPA1 to produce inhibition of sodium channels and cytotoxicity","volume":"124","author":"Stueber","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coph.2024.102433_sref5","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1111\/bph.15531","article-title":"Inhibition of inflammatory pain and cough by a novel charged sodium channel blocker","volume":"178","author":"Tochitsky","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2024.102433_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb8828","article-title":"Neurotoxic peptides from the venom of the giant Australian stinging tree","volume":"6","author":"Gilding","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.coph.2024.102433_sref7","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/s41467-023-37963-2","article-title":"Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function","volume":"14","author":"Jami","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2024.102433_bib8","article-title":"The tarantula venom peptide Eo1a binds to the domain II S3-S4 extracellular loop of voltage-gated sodium channel NaV1.8 to enhance activation","volume":"12","author":"Deuis","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2024.102433_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.1236451","article-title":"Voltage-gated sodium channel in grasshopper mice defends against bark scorpion toxin","volume":"342","author":"Rowe","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coph.2024.102433_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.846992","article-title":"Structural and functional characterization of a novel scorpion toxin that inhibits NaV1.8 via interactions with the DI voltage sensor and DII pore module","volume":"13","author":"George","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2024.102433_bib11","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1073\/pnas.0611364104","article-title":"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat","volume":"104","author":"Jarvis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2024.102433_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/j.pain.0000000000001399","article-title":"Targeting the Nav1.8 ion channel engenders sex-specific responses in lysophosphatidic acid-induced joint neuropathy","volume":"160","author":"O'Brien","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.coph.2024.102433_bib13","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar3553","article-title":"Involvement of Nav 1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis","volume":"14","author":"Schuelert","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coph.2024.102433_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208211119","article-title":"Structural basis for high-voltage activation and subtype-specific inhibition of human Nav1.8","volume":"119","author":"Huang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2024.102433_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842032","article-title":"Towards structure-guided development of pain therapeutics targeting voltage-gated sodium channels","volume":"13","author":"Nguyen","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2024.102433_bib16","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1242\/jcs.026856","article-title":"The voltage-gated Na+ channel Nav1.8 contains an ER-retention\/retrieval signal antagonized by the beta3 subunit","volume":"121","author":"Zhang","year":"2008","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.coph.2024.102433_bib17","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1046\/j.1460-9568.2000.00294.x","article-title":"beta3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain","volume":"12","author":"Shah","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.coph.2024.102433_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nature00781","article-title":"Annexin II light chain regulates sensory neuron-specific sodium channel expression","volume":"417","author":"Okuse","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.coph.2024.102433_bib19","doi-asserted-by":"crossref","first-page":"10499","DOI":"10.1523\/JNEUROSCI.1997-06.2006","article-title":"Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior","volume":"26","author":"Foulkes","year":"2006","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.coph.2024.102433_bib20","doi-asserted-by":"crossref","first-page":"31375","DOI":"10.1074\/jbc.M109.009951","article-title":"An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels","volume":"284","author":"Brittain","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2024.102433_bib21","doi-asserted-by":"crossref","first-page":"E8443","DOI":"10.1073\/pnas.1610531113","article-title":"Hierarchical CRMP2 posttranslational modifications control Nav1.7 function","volume":"113","author":"Dustrude","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2024.102433_bib22","doi-asserted-by":"crossref","first-page":"eabh1314","DOI":"10.1126\/scitranslmed.abh1314","article-title":"Selective targeting of Nav1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents","volume":"13","author":"Cai","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2024.102433_sref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336950.2021.2023383","article-title":"Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats","volume":"16","author":"Li","year":"2022","journal-title":"Channels"},{"key":"10.1016\/j.coph.2024.102433_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.coph.2024.102433_bib25","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1097\/j.pain.0000000000002171","article-title":"Two independent mouse lines carrying the Nav1.7 I228M gain-of-function variant display dorsal root ganglion neuron hyperexcitability but a minimal pain phenotype","volume":"162","author":"Chen","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.coph.2024.102433_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114393","article-title":"Nav1.7 gain-of-function mutation I228M triggers age-dependent nociceptive insensitivity and C-LTMR dysregulation","volume":"364","author":"Wimalasena","year":"2023","journal-title":"Exp Neurol"},{"key":"10.1016\/j.coph.2024.102433_sref27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9056","article-title":"Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice","volume":"13","author":"Moreno","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2024.102433_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217800120","article-title":"Identification and targeting of a unique NaV1.7 domain driving chronic pain","volume":"120","author":"Gomez","year":"2023","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489224000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489224000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:58:38Z","timestamp":1761461918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489224000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"alternative-id":["S1471489224000031"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2024.102433","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic potential of voltage gated sodium channel modulators for the management of pain","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2024.102433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102433"}}